Literature DB >> 12212730

Susceptibility of bovine umbilical cord endothelial cells to bovine herpesviruses and pseudocowpox virus.

G J Wellenberg1, E R A M Verstraten, F Jongejan, J T Van Oirschot.   

Abstract

The purpose of the study was to determine the susceptibility of bovine umbilical cord endothelial (BUE) cells to bovine herpesvirus (BHV) 1, BHV2, BHV4 and BHV5, and to pseudocowpox virus. The detection limits and growth curves of these viruses in BUE cells were compared with those in Vero, Madin-Darby bovine kidney (MDBK). or bovine fetal diploid lung (BFDL) cells. Detection limits were determined by inoculating cell cultures with serial 10-fold dilutions of these viruses, and growth curves by titration of virus, harvested at various times after infecting cells at a multiplicity of infection of 0.1. The detection limits of BHV2 and BHV4 were lower in BUE cells than in Vero or MDBK cells, and cytopathic effects were observed earlier in BUE cells. In addition, BHV2 and BHV4 grew to higher titres in BUE cells than in Vero or MDBK cells. BUE cells appeared to be equally susceptible to BHV5, but less susceptible to BHV1.1 and BHVI.2 than MDBK cells. The study showed that BUE cells are highly susceptible to BHV2 and BHV4. and that the use of BUE cells can improve the laboratory diagnosis of these viruses. The use of BUE cells could also improve the isolation and growth of pseudocowpox virus.

Entities:  

Mesh:

Year:  2002        PMID: 12212730     DOI: 10.1023/a:1016203130519

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  17 in total

1.  Experimental infection with bovine herpesvirus-4 enhances atherosclerotic process in rabbits.

Authors:  T M Lin; M J Jiang; H L Eng; G Y Shi; L C Lai; B J Huang; K Y Huang; H L Wu
Journal:  Lab Invest       Date:  2000-01       Impact factor: 5.662

2.  Persistent infection of bovine herpesvirus type 4 in bovine endothelial cell cultures.

Authors:  T M Lin; G Y Shi; S J Jiang; C F Tsai; B J Hwang; C T Hsieh; H L Wu
Journal:  Vet Microbiol       Date:  1999-10       Impact factor: 3.293

3.  Tissue distribution of bovid herpesvirus-4 in inoculated rabbits and its detection by DNA hybridization and polymerase chain reaction.

Authors:  K Naeem; M P Murtaugh; S M Goyal
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Susceptibility of endothelial cells to bovine herpesvirus type 4 (BHV-4).

Authors:  T M Lin; G Y Shi; C F Tsai; H J Su; Y L Guo; H L Wu
Journal:  J Virol Methods       Date:  1997-01       Impact factor: 2.014

5.  Rapid herpes simplex virus detection in clinical samples submitted to a state virology laboratory.

Authors:  D R Mayo; T Brennan; S H Egbertson; D F Moore
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

6.  Detection and diagnosis of parapoxvirus by the polymerase chain reaction.

Authors:  Y Inoshima; A Morooka; H Sentsui
Journal:  J Virol Methods       Date:  2000-02       Impact factor: 2.014

7.  Biochemical and electron microscopic studies of the replication and composition of milker's node virus.

Authors:  V Thomas; L Flores; J A Holowczak
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

8.  Synergic action between tumor necrosis factor and endotoxins or poly(A.U) on cultured bovine endothelial cells.

Authors:  P A van de Wiel; R H Pieters; A van der Pijl; N Bloksma
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

9.  Replication of equid herpesvirus 4 in endothelial cells and synovia of a field case of viral pneumonia and synovitis in a foal.

Authors:  A S Blunden; K C Smith; M M Binns; L Zhang; S M Gower; J A Mumford
Journal:  J Comp Pathol       Date:  1995-02       Impact factor: 1.311

10.  European isolates of bovine herpesvirus 1: a comparison of restriction endonuclease sites, polypeptides, and reactivity with monoclonal antibodies.

Authors:  A E Metzler; H Matile; U Gassmann; M Engels; R Wyler
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.